Canadian Cancer Trials Group Bulletins

Ethics Regulatory


Annual Re-Approvals

The Canadian Cancer Trials Group has amended its annual re-approval policy.

(1) For all trials, annual re-approval is required until patients are no longer being followed and data are no longer being collected in a centre.
(2) If the local REB requires that annual re-approval continue until data is no longer being queried, it is the responsibility of the centre to ensure that annual re-approval is obtained according to local policy.
(3) Centres may use an anniversary date provided that the full board meeting is within 30 days prior to that date. (Previously, the anniversary date could only be used if the full board meeting/approval was within 30 days prior to that date and the anniversary date had to be the date of the previous year's full board meeting/approval date.)

Questions about these changes should be directed to Erin Bell, ER Team Leader, at 613-533-6430 or ebell@ctg.queensu.ca.